CLINICAL TRIALS PROFILE FOR NORCOCAINE
✉ Email this page to a colleague
Clinical Trials for Norcocaine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00969878 ↗ | Multisite Controlled Trial of Cocaine Vaccine | Completed | Celtic Pharma Development Services | Phase 2 | The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD). |
NCT00969878 ↗ | Multisite Controlled Trial of Cocaine Vaccine | Completed | Columbia University | Phase 2 | The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD). |
NCT00969878 ↗ | Multisite Controlled Trial of Cocaine Vaccine | Completed | Johns Hopkins University | Phase 2 | The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD). |
NCT00969878 ↗ | Multisite Controlled Trial of Cocaine Vaccine | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD). |
NCT00969878 ↗ | Multisite Controlled Trial of Cocaine Vaccine | Completed | University of Cincinnati | Phase 2 | The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD). |
NCT00969878 ↗ | Multisite Controlled Trial of Cocaine Vaccine | Completed | University of Pennsylvania | Phase 2 | The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Norcocaine
Condition Name
Clinical Trial Locations for Norcocaine
Trials by Country
Clinical Trial Progress for Norcocaine
Clinical Trial Phase
Clinical Trial Sponsors for Norcocaine
Sponsor Name